Form 4: Director Alan Bazaar Increases Stake in Orthofix Medical

Orthofix Medical Inc. director Alan Lee Bazaar has been granted 14,965 deferred stock units as part of his compensation.

Summary

• Director Alan Lee Bazaar acquired 14,965 deferred stock units (DSUs) on June 10, 2026.
• The DSUs represent a contingent right to receive one share of common stock per unit.
• The units vest in full on the first anniversary of the grant date, contingent upon continued service.
• Following this transaction, the director's total beneficial ownership increased to 65,489 shares.
• The total includes 42,929 previously reported DSUs and 700 shares acquired via the company's Stock Purchase Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of director compensation that does not signal a change in company strategy or financial health.

Positives

• Director alignment with shareholder interests through increased equity-based compensation.
• Continued participation in the company's Stock Purchase Plan indicates long-term commitment.

Negatives

• None identified; this is a standard equity grant for a board member.

Risks

• Vesting of the units is subject to the director's continued service with the issuer.

Future Outlook

The deferred stock units will vest on June 10, 2027, and will settle into common stock within 45 days of the director's eventual termination of service.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard practice in the medical device sector to ensure long-term alignment between directors and shareholders.

Comparison to Industry Standards

• The grant of deferred stock units is consistent with standard corporate governance practices for publicly traded medical technology companies.
• The use of a Stock Purchase Plan for directors is a common mechanism to encourage personal investment in the company.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation event.

Next Steps

• Vesting of the 14,965 deferred stock units on June 10, 2027.

Key Dates

Keywords

Orthofix Medical, OFIX, Director Compensation, Insider Transaction, Form 4, Equity Grant